$AM

Antero Midstream (AM) Q2 2026 Earnings Call Transcript

Antero Midstream (NYSE:AM) reported Q2 2026 results on an earnings call. The company said it gathered 4.1 Bcf/d, up nearly 20% YoY, and posted adjusted EBITDA of $289 million. Free cash flow after dividends was $80 million. It received $370 million+ in Veolia legal settlement proceeds, used to reduce debt, and discussed the Eastside Express pipeline project and high single-digit EBITDA growth guidance.

Original reporting
Published Aug 8, 2026, 1:14 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 8, 2026, 1:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Antero Midstream (AM) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$AMBullishMed
01

Why it matters

AM’s disclosed Q2 operating strength, Q3 sequential EBITDA guidance, and leverage reduction plan (via Veolia settlement proceeds and debt retirement) are the main drivers for near-term trading decisions.

02

Market read

Traders can update expectations for AM’s near-term EBITDA trajectory and balance-sheet trajectory based on the call’s Q2 record metrics, Q3 guidance, and leverage below the 3x target.

03

What to watch

The article cites curtailment impact of ~0.3% and large planned CapEx for Eastside Express; traders may need to watch execution risk, timing of phased capacity, and any changes in customer demand or gathering economics.

Relevance 8/10Novelty 7/10Timing: ahead of Q3 2026 trading, post-call positioning

Background

This is a transcript-style summary of Antero Midstream’s Q2 2026 earnings call, covering volumes, EBITDA, free cash flow, leverage, and the Eastside Express pipeline project.

Company-level read

Ticker impact

$AMBullishMedium confidence
Context

Antero Midstream reported Q2 2026 record adjusted EBITDA of $289M, 4.1 Bcf/d volumes, and guided Q3 EBITDA to high single-digit sequential growth.

Expected impact

Bias toward upside for AM on expectations of sustained volume growth, lower leverage after the Veolia settlement, and incremental EBITDA from Eastside Express.

Evidence & confidence

Key new items include Q2 results, Q3 sequential EBITDA guidance, leverage at 2.8x, and $370M+ legal settlement proceeds used for accelerated debt reduction, all of which can move valuation and credit-spread expectations.

Market effects

Reinforces the Appalachia dry gas midstream narrative, with connectivity projects and water-system integration framed as drivers of incremental throughput and EBITDA.

Eastside Express pipeline is positioned to increase regional market optionality in West Virginia, potentially improving gas access to power and data-center demand.

Limited direct global linkage; primarily a regional natural gas infrastructure and credit-quality story.

Counterpoint

Guidance is sequential and growth is described as high single-digit; if volumes or project phasing slip, the market may fade the optimism quickly.

Key entities

  • Antero Midstream Corporation

    Subject of the earnings call, reporting record Q2 2026 results and providing Q3/2027 growth and project updates.

  • Veolia

    Settlement counterparty; AM received over $370M in damages and interest in July to accelerate debt reduction.

  • Eastside Express pipeline project

    Connectivity initiative with planned capacity of 1.5 to 2.0 Bcf/d and multi-year phased CapEx of $200M to $300M.

Related articles

$AMMed

Antero Midstream Corp (AM): Results of Operations and Financial Condition

Antero Midstream Corp (AM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2621395d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Antero Midstream Announces Second Quarter 2026 Financial and Operating Results Denver, Colorado, July 29, 2026—Antero Midstream Corporation (NYSE: AM) (“Antero Midstream” or the “Company”) today announced its second quart

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.

$KRMNMed

Karman Q2 Earnings Call Highlights

Karman (NYSE:KRMN) reaffirmed full-year organic growth of 25% or more after Q2 organic revenue rose 24.4% YoY. Management expects second-half revenue to rise sequentially, with Tactical Missiles and IDS, Hypersonics, and Space and Launch as key drivers. Karman converted one contingent supply agreement into a firm contract and plans capacity expansion, plus a £70m ($94m) Walker Precision acquisition.